LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $287,407 | -56.7% | 195,515 | -6.3% | 0.00% | – |
Q2 2023 | $663,577 | +81220.7% | 208,672 | -39.7% | 0.00% | – |
Q1 2023 | $816 | -99.9% | 345,955 | +22.7% | 0.00% | -100.0% |
Q1 2022 | $1,423,000 | -52.7% | 281,855 | -27.4% | 0.00% | -50.0% |
Q4 2021 | $3,006,000 | +209.9% | 388,381 | +492.8% | 0.00% | +100.0% |
Q3 2021 | $970,000 | -54.5% | 65,515 | -50.0% | 0.00% | 0.0% |
Q2 2021 | $2,130,000 | – | 131,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |